CITED2 anticorps (AA 1-275)

N° du produit ABIN6138641

Détail du produit anti-CITED2 anticorps

Antigène: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Épitope: AA 1-275

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CITED2 est non-conjugé

Application: Western Blotting (WB)

Séquence: MSGLEMADHM MAMNHGRFPD GTNGLHHHPA HRMGMGQFPS PHHHQQQQPQ HAFNALMGEH IHYGAGNMNA TSGIRHAMGP GTVNGGHPPS ALAPAARFNN SQFMGPPVAS QGGSLPASMQ LQKLNNQYFN HHPYPHNHYM PDLHPAAGHQ MNGTNQHFRD CNPKHSGGSS TPGGSGGSST PGGSGSSSGG GAGSSNSGGG SGSGNMPASV AHVPAAMLPP NVIDTDFIDE EVLMSLVIEM GLDRIKELPE LWLGQNEFDF MTDFVCKQQP SRVSC

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 1-275 of human CITED2 (NP_001161861.2).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur CITED2

Antigène: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Autre désignation: CITED2 (CITED2 Produits)

Synonymes: anticorps mrg1, anticorps p35srj, anticorps zgc:103418, anticorps CITED2, anticorps cite2, anticorps ASD8, anticorps MRG-1, anticorps MRG1, anticorps P35SRJ, anticorps VSD2, anticorps AI835299, anticorps ER154-like, anticorps Mrg1, anticorps Msg2, anticorps Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2, anticorps Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2, anticorps Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2, anticorps Cbp/p300-interacting transactivator 2, anticorps Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 L homeolog, anticorps cited2, anticorps CITED2, anticorps cite2, anticorps Cited2, anticorps cited2.L

Sujet: The protein encoded by this gene inhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1. Mutations in this gene are a cause of cardiac septal defects. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.,CITED2,ASD8,MRG-1,MRG1,P35SRJ,VSD2,Epigenetics & Nuclear Signaling,Nuclear Receptor Signaling,Cancer,Invasion and Metastasis,Endocrine & Metabolism,Cardiovascular,Hypoxia,Hypoxia-related proteins,Hypoxia-Regulated,CITED2

Poids moléculaire: 23 kDa/28 kDa

ID gène: 10370

UniProt: Q99967

Pathways: Tube Formation